UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October, 2016
Commission File Number: 001-13742
ISRAEL CHEMICALS LTD.
(Exact name of registrant as specified in its charter)
Israel Chemicals Ltd.
Millennium Tower
23 Aranha Street
P.O. Box 20245
Tel Aviv, 61202 Israel
(972-3) 684-4400
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F |
X |
|
Form 40-F |
|
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes |
|
|
No |
X |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes |
|
|
No |
X |
|
ISRAEL CHEMICALS LTD.
INCORPORATION BY REFERENCE
This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
|
Final arbitrator’s Award ending dispute with Haifa Chemicals
Further to Note 23 of the Company’s financial statements for 2015 and to Note 8 of the Company's financial statements for the second quarter of 2016, regarding the dispute between the subsidiary Dead Sea Works Ltd. (“DSW”) and Haifa Chemicals Ltd. ("Haifa Chemicals"), the Company hereby reports that the final award ending the arbitration was rendered yesterday with the consent of both parties (the “Arbitration Award”).
All past disputes and legal claims currently pending between the parties relating to the Principal Arbitration Award rendered in 2014 and referring to potash sales for the years 2009 to 2016, inclusive, will be dismissed in a manner not impacting DSW by way of further payments or receivables. The execution of the Arbitration Award will be deemed as the full and complete execution of all the obligations stipulated by the 2014 Principal Arbitration Award.
The main principles of the Arbitration Award are as follows:
Based on the above mentioned, the impact on the Company's financial statements is not expected to be material.
Name of the authorized signatory on the report and name of authorized electronic reporter: Lisa Haimovitz
Position: SVP, Global General Counsel and Company Secretary
Signature Date: October 26, 2016
INVESTOR RELATIONS CONTACT PRESS CONTACT
Limor Gruber Gadi Ohana
Head of Investor Relations, ICL Debby Communications
+972-3-684-4471 +972-3-5683000
Limor.Gruber@icl-group.com gadi@debby.co.il
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
Israel Chemicals Ltd. |
|||
|
|
|
|||
|
|
|
By: |
/s/ Kobi Altman |
|
|
|
|
|
Name: |
Kobi Altman |
|
|
|
|
Title: |
Chief Financial Officer |
|
|
Israel Chemicals Ltd. |
|||
|
|
|
|||
|
|
|
By: |
/s/ Lisa Haimovitz |
|
|
|
|
|
Name: |
Lisa Haimovitz |
|
|
|
|
Title: |
Senior Vice President, Global General Counsel and Corporate Secretary |
Date: October 26, 2016
|